Related Experiment Video

Updated: Oct 7, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

Negative regulation of Janus kinases

R J Duhé1, L H Wang, W L Farrar

  • 1Department of Pharmacology and Toxicology, University of Mississippi Medical Center, Jackson 39216-4505, USA. rduhe@pharmacology.umsmed.edu

Cell Biochemistry and Biophysics
|June 8, 2001
PubMed

Insights

Precise Janus kinase (JAK) regulation is vital for biological processes. Dysregulated JAK activity, from inhibition to overactivation, causes diseases like immunodeficiency and leukemia, necessitating therapeutic interventions.

Area of Science:

  • Molecular Biology
  • Immunology
  • Oncology

Background:

  • Janus kinases (JAKs) are crucial for cytokine signaling, influencing numerous biological processes.
  • Dysregulation of JAK activity is linked to pathological conditions, including immunosuppression (e.g., X-linked severe combined immunodeficiency) and cancers (e.g., leukemias).
  • JAKs are increasingly recognized for their role beyond classic cytokine receptor pathways, integrating into other signaling cascades.

Purpose of the Study:

  • To review the mechanisms of negative regulation of Janus kinase (JAK) activity.
  • To highlight therapeutic strategies aimed at restoring aberrant JAK activity to normal levels.
  • To discuss emerging physiological and pharmacological approaches for JAK pathway modulation.

Main Methods:

  • Review of literature on JAK regulation and therapeutic interventions.
  • Analysis of suppressors of cytokine signaling (SOCS) proteins as physiological inhibitors.
  • Examination of novel pharmacological agents, such as dimethoxyquinazoline derivatives.
  • Exploration of JAK interactions with phosphatases and redox regulation.
  • Discussion of JAK expression suppression by endogenous or exogenous agents.

Main Results:

  • JAK catalytic activity requires precise control of both magnitude and duration.
  • Inappropriate JAK inhibition leads to immunosuppressive states, while enhanced JAK activity contributes to certain cancers.
  • Novel therapeutic strategies, including protein-based inhibitors and small molecules, are emerging to modulate JAK activity.
  • Negative regulation of JAKs involves complex mechanisms including SOCS, phosphatases, and redox control.

Conclusions:

  • Restoring normal JAK activity is a key therapeutic goal for various diseases.
  • Understanding the diverse mechanisms of JAK regulation is essential for developing effective treatments.
  • Future research directions include further exploration of JAK interactions and the development of targeted therapies.

More Related Videos

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway08:15

Antagonistic Effect of Jiawei Shengjiang San on a Rat Model of Diabetic Nephropathy: Related to EGFR/MAPK3/1 Signaling Pathway

Published on: May 10, 2024

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...